Frontiers in pruritus research: Scratching the brain for more effective itch therapy

Ralf Paus, Martin Schmelz, Tamás Bíró, Martin Steinhoff

Research output: Contribution to journalReview article

268 Citations (Scopus)

Abstract

This Review highlights selected frontiers in pruritus research and focuses on recently attained insights into the neurophysiological, neuroimmunological, and neuroendocrine mechanisms underlying skin-derived itch (pruritogenic pruritus), which may affect future antipruritic strategies. Special attention is paid to newly identified itch-specific neuronal pathways in the spinothalamic tract that are distinct from pain pathways and to CNS regions that process peripheral pruritogenic stimuli. In addition, the relation between itch and pain is discussed, with emphasis on how the intimate contacts between these closely related yet distinct sensory phenomena may be exploited therapeutically. Furthermore, newly identified or unduly neglected intracutaneous itch mediators (e.g., endovanilloids, proteases, cannabinoids, opioids, neurotrophins, and cytokines) and relevant receptors (e.g., vanilloid receptor channels and proteinase-activated, cannabinoid, opioid, cytokine, and new histamine receptors) are discussed. In summarizing promising new avenues for managing itch more effectively, we advocate therapeutic approaches that strive for the combination of peripherally active antiinflammatory agents with drugs that counteract chronic central itch sensitization.

Original languageEnglish (US)
Pages (from-to)1174-1185
Number of pages12
JournalJournal of Clinical Investigation
Volume116
Issue number5
DOIs
StatePublished - May 1 2006
Externally publishedYes

Fingerprint

Cannabinoids
Pruritus
Opioid Analgesics
Peptide Hydrolases
Antipruritics
Spinothalamic Tracts
Central Nervous System Sensitization
TRPV Cation Channels
Histamine Receptors
Pain
Cytokine Receptors
Nerve Growth Factors
Brain
Research
Anti-Inflammatory Agents
Cytokines
Skin
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Frontiers in pruritus research : Scratching the brain for more effective itch therapy. / Paus, Ralf; Schmelz, Martin; Bíró, Tamás; Steinhoff, Martin.

In: Journal of Clinical Investigation, Vol. 116, No. 5, 01.05.2006, p. 1174-1185.

Research output: Contribution to journalReview article

Paus, Ralf ; Schmelz, Martin ; Bíró, Tamás ; Steinhoff, Martin. / Frontiers in pruritus research : Scratching the brain for more effective itch therapy. In: Journal of Clinical Investigation. 2006 ; Vol. 116, No. 5. pp. 1174-1185.
@article{d5df5ad44b964f0c8fc5f680d7d80d92,
title = "Frontiers in pruritus research: Scratching the brain for more effective itch therapy",
abstract = "This Review highlights selected frontiers in pruritus research and focuses on recently attained insights into the neurophysiological, neuroimmunological, and neuroendocrine mechanisms underlying skin-derived itch (pruritogenic pruritus), which may affect future antipruritic strategies. Special attention is paid to newly identified itch-specific neuronal pathways in the spinothalamic tract that are distinct from pain pathways and to CNS regions that process peripheral pruritogenic stimuli. In addition, the relation between itch and pain is discussed, with emphasis on how the intimate contacts between these closely related yet distinct sensory phenomena may be exploited therapeutically. Furthermore, newly identified or unduly neglected intracutaneous itch mediators (e.g., endovanilloids, proteases, cannabinoids, opioids, neurotrophins, and cytokines) and relevant receptors (e.g., vanilloid receptor channels and proteinase-activated, cannabinoid, opioid, cytokine, and new histamine receptors) are discussed. In summarizing promising new avenues for managing itch more effectively, we advocate therapeutic approaches that strive for the combination of peripherally active antiinflammatory agents with drugs that counteract chronic central itch sensitization.",
author = "Ralf Paus and Martin Schmelz and Tam{\'a}s B{\'i}r{\'o} and Martin Steinhoff",
year = "2006",
month = "5",
day = "1",
doi = "10.1172/JCI28553",
language = "English (US)",
volume = "116",
pages = "1174--1185",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

TY - JOUR

T1 - Frontiers in pruritus research

T2 - Scratching the brain for more effective itch therapy

AU - Paus, Ralf

AU - Schmelz, Martin

AU - Bíró, Tamás

AU - Steinhoff, Martin

PY - 2006/5/1

Y1 - 2006/5/1

N2 - This Review highlights selected frontiers in pruritus research and focuses on recently attained insights into the neurophysiological, neuroimmunological, and neuroendocrine mechanisms underlying skin-derived itch (pruritogenic pruritus), which may affect future antipruritic strategies. Special attention is paid to newly identified itch-specific neuronal pathways in the spinothalamic tract that are distinct from pain pathways and to CNS regions that process peripheral pruritogenic stimuli. In addition, the relation between itch and pain is discussed, with emphasis on how the intimate contacts between these closely related yet distinct sensory phenomena may be exploited therapeutically. Furthermore, newly identified or unduly neglected intracutaneous itch mediators (e.g., endovanilloids, proteases, cannabinoids, opioids, neurotrophins, and cytokines) and relevant receptors (e.g., vanilloid receptor channels and proteinase-activated, cannabinoid, opioid, cytokine, and new histamine receptors) are discussed. In summarizing promising new avenues for managing itch more effectively, we advocate therapeutic approaches that strive for the combination of peripherally active antiinflammatory agents with drugs that counteract chronic central itch sensitization.

AB - This Review highlights selected frontiers in pruritus research and focuses on recently attained insights into the neurophysiological, neuroimmunological, and neuroendocrine mechanisms underlying skin-derived itch (pruritogenic pruritus), which may affect future antipruritic strategies. Special attention is paid to newly identified itch-specific neuronal pathways in the spinothalamic tract that are distinct from pain pathways and to CNS regions that process peripheral pruritogenic stimuli. In addition, the relation between itch and pain is discussed, with emphasis on how the intimate contacts between these closely related yet distinct sensory phenomena may be exploited therapeutically. Furthermore, newly identified or unduly neglected intracutaneous itch mediators (e.g., endovanilloids, proteases, cannabinoids, opioids, neurotrophins, and cytokines) and relevant receptors (e.g., vanilloid receptor channels and proteinase-activated, cannabinoid, opioid, cytokine, and new histamine receptors) are discussed. In summarizing promising new avenues for managing itch more effectively, we advocate therapeutic approaches that strive for the combination of peripherally active antiinflammatory agents with drugs that counteract chronic central itch sensitization.

UR - http://www.scopus.com/inward/record.url?scp=33646418808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646418808&partnerID=8YFLogxK

U2 - 10.1172/JCI28553

DO - 10.1172/JCI28553

M3 - Review article

C2 - 16670758

AN - SCOPUS:33646418808

VL - 116

SP - 1174

EP - 1185

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -